FDA Investigator

Stephon D Tillis

Latest inspection on record: Coppell, United States, November 2025 · records back to 2024

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 9 inspections across 9 sites are on record.
  • 30 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-11-03.

At a glance

Inspections

9

Sites

9

Observations

30

Career since

Oct 2024

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Beauty Manufacturing Solutions Corp.3 Nov 2025Human DrugsView 483 →
OraLabs, Incorporated2 Oct 2025Human DrugsView 483 →
Acme United Corporation20 Aug 2025Human Drugs
Signature Formulations, LLC29 Jul 2025Human DrugsView 483 →
Analytical Food Laboratories Inc.20 Jun 2025Human DrugsView 483 →

Sites inspected

Beauty Manufacturing Solutions Corp.Coppell, United States1 insp.
OraLabs, IncorporatedParker, United States1 insp.
Acme United CorporationRocky Mount, United States1 insp.
Signature Formulations, LLCPhoenix, United States1 insp.
Analytical Food Laboratories Inc.Grand Prairie, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Jeffrey T Prosterman3 shared
Mercedes N Overton3 shared
Inga M Warr1 shared
Hala L Selby1 shared

Full investigator report

Get the verbatim findings behind Stephon D Tillis' 30 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site